Tranexamic acid reduces blood loss after primary shoulder arthroplasty: a double-blind, placebo-controlled, prospective, randomized controlled trial

BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic that has been shown to decrease blood loss and transfusion rates after hip and knee arthroplasty, with only limited evidence to support its use in shoulder arthroplasty. This study was conducted to determine whether intravenous (IV) TXA is mor...

Descripción completa

Detalles Bibliográficos
Autores principales: Cvetanovich, Gregory L., Fillingham, Yale A., O'Brien, Michael, Forsythe, Brian, Cole, Brian J., Verma, Nikhil N., Romeo, Anthony A., Nicholson, Gregory P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334853/
https://www.ncbi.nlm.nih.gov/pubmed/30675563
http://dx.doi.org/10.1016/j.jses.2018.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6334853/
https://www.ncbi.nlm.nih.gov/pubmed/30675563
http://dx.doi.org/10.1016/j.jses.2018.01.002

Ejemplares similares